https://www.selleckchem.com/pr....oducts/ll37-human.ht
05 to p less then 0.001). Beyond lipid lowering, rosuvastatin treatment reduced total and differential WBC counts in the A and AH groups (p less then 0.05 to p less then 0.001), IL-6 level in the AH group (p less then 0.05), and IL-10 level in all treated groups (p less then 0.05). Rosuvastatin reduced oxidative stress by decreasing nitrite and malondialdehyde concentrations, and increasing total thiol content in all treated groups as well as superoxide dismutase and catalase activities in the H and AH groups (p less then 0.05 to p l
Like
Comment
Share
